Cardlytics, Inc.
CDLX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.16 | 0.03 | -0.00 | -0.19 |
| FCF Yield | -15.67% | -3.74% | -34.89% | -2.40% |
| EV / EBITDA | -2.20 | -5.15 | -0.73 | -23.27 |
| Quality | ||||
| ROIC | -66.57% | -33.49% | -30.21% | -9.68% |
| Gross Margin | 43.44% | 42.17% | 37.73% | 38.69% |
| Cash Conversion Ratio | 0.05 | 0.00 | 0.12 | 0.30 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.31% | 5.00% | 16.90% | 8.28% |
| Free Cash Flow Growth | -123.60% | 81.34% | -31.91% | -188.38% |
| Safety | ||||
| Net Debt / EBITDA | -1.02 | -1.76 | -0.27 | 0.40 |
| Interest Coverage | -21.96 | -21.94 | -33.94 | -7.53 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 2,323.88 | 1,723.96 |
| Cash Conversion Cycle | 131.85 | 139.71 | 139.57 | 150.04 |